Dimitrios Angelis

Dimitrios Angelis, JD has been working in the field since 2008. Dimitrios began their career as a Member Board of Directors for Habitat for Humanity. In 2015, they became a Board Member, Member Board of Directors for Digirad (NASDAQ: DRAD) and Ameri100 (NASDAQ: AMRH). In 2017, they took on the roles of Co-Founder for Sparta Biomedical and Sparta Biopharma, Managing Partner for Pharma Tech Law, General Counsel for Relevale and Bond, and Member Board of Directors for The ONE Group (NASDAQ: STKS). In 2019, they became Co-Founder of GenDeep Inc.

Dimitrios Angelis, JD completed their Bachelor of Arts degree in Philosophy and English Literature from Boston College in 1992. Dimitrios then went on to pursue a Master of Arts degree from California State University-Dominguez Hills, which they completed in 1994. In 1998, they began their JD degree at New York University School of Law and completed it in 2001. Dimitrios has also obtained Bar Admission in New Jersey and New York from the State Bar Association.